Showing results (31-40 of 127) with videos related to
Sort By:
Pageof 13
Cancer Research|January 18, 2008
Superior activity of fusion protein scFvRit:sFasL over cotreatment with rituximab and Fas agonistsEdwin Bremer, Bram ten Cate, Douwe F Samplonius, et al.Plos One|June 7, 2013
Galectin-9 activates and expands human T-helper 1 cellsMarloes J M Gooden, Valerie R Wiersma, Douwe F Samplonius, et al.Mabs|March 12, 2015
C-type lectin-like molecule-1 (CLL1)-targeted TRAIL augments the tumoricidal activity of granulocytes and potentiates therapeutic antibody-dependent cell-mediated cytotoxicityValerie R Wiersma, Marco de Bruyn, Ce Shi, et al.Cancer Immunology, Immunotherapy : CII|August 1, 2007
Selective induction of apoptosis in leukemic B-lymphoid cells by a CD19-specific TRAIL fusion proteinJulia Stieglmaier, Edwin Bremer, Christian Kellner, et al.Methods in Molecular Biology (Clifton, N.J.)|May 22, 2025
A Luminescence-Based Method for In Vitro Screening of Immunomodulatory Checkpoints and TherapeuticsJimena Álvarez Freile, Edwin BremerOncoimmunology|January 9, 2018
CD20-selective inhibition of CD47-SIRPα "don't eat me" signaling with a bispecific antibody-derivative enhances the anticancer activity of daratumumab, alemtuzumab and obinutuzumabPeter E van Bommel, Yuan He, Ilona Schepel, et al.Autophagy|June 19, 2015
The epithelial polarity regulator LGALS9/galectin-9 induces fatal frustrated autophagy in KRAS mutant colon carcinoma that depends on elevated basal autophagic fluxValerie R Wiersma, Marco de Bruyn, Yunwei Wei, et al.International Journal of Molecular Sciences|April 17, 2025
Enhancing the Anticancer Activity of a Carcinoma-Directed Peptide-HLA-I Fusion Protein by Armoring with Mutein IFNαDouwe Freerk Samplonius, Anne Paulien van Wijngaarden, Lisanne Koll, et al.Cancers|July 29, 2025
CD19-ReTARGTPR: A Novel Fusion Protein for Physiological Engagement of Anti-CMV Cytotoxic T Cells Against CD19-Expressing MalignanciesAnne Paulien van Wijngaarden, Isabel Britsch, Matthias Peipp, et al.Frontiers in Cell and Developmental Biology|June 17, 2022
Towards Immunotherapy-Induced Normalization of the Tumor MicroenvironmentVinicio Melo, Edwin Bremer, John D MartinPageof 13